Cardiology overview prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
(Replaced content with "{{Cardiology overview}} {{CMG}} ==References== {{Reflist|2}} {{WS}} {{WH}}")
 
Line 2: Line 2:
{{CMG}}
{{CMG}}


==Statin Therapy==
===Drug Interactions===
*[[Cyclosporin]] co-administration is associated with a higher rate of [[myositis]] among statin users as a result of inhibition of [[CYP3A4]]. The exception is [[pravastatin]] in which this is not a problem.
===Myositis===
* The risk of [[myositis]] is lowest with [[pravastatin]] and is not improved with switching to [[atorvastatin]]. [[Simvastatin]] at a dose of 80 mg is associated with a particularly high incidence of myositis.
===Reducing non-myositis Muscle Pain===
* [[Coenzyme Q]] can be used to reduce the incidence of non-[[myositis]] muscle pain.  Several weeks of coenzyme Q should be administered prior to trying the combination of the agent with statin therapy.


==References==
==References==

Latest revision as of 00:52, 4 November 2011